Long-term assessment of drug safety and efficacy.
作者信息
Turner P
出版信息
J R Soc Med. 1984 Feb;77(2):93-4. doi: 10.1177/014107688407700201.
Abstract
摘要
相似文献
1
Long-term assessment of drug safety and efficacy.
J R Soc Med. 1984 Feb;77(2):93-4. doi: 10.1177/014107688407700201.
2
Postmarketing surveillance of adverse reactions to drugs.
Br Med J (Clin Res Ed). 1984 Mar 24;288(6421):879-80. doi: 10.1136/bmj.288.6421.879.
3
Postmarketing surveillance of adverse reactions to drugs.
Br Med J (Clin Res Ed). 1984 Apr 14;288(6424):1155-6. doi: 10.1136/bmj.288.6424.1155.
4
Drug safety.
Lancet. 1984 Nov 10;2(8411):1098-9. doi: 10.1016/s0140-6736(84)91536-8.
5
Adverse reactions to new drugs.
Br Med J (Clin Res Ed). 1983 Mar 26;286(6370):1052-3. doi: 10.1136/bmj.286.6370.1052.
6
Why do doctors not report adverse drug reactions?
Neth J Med. 1985;28(12):546-50.
7
Post-marketing surveillance or drug acceptability study?
Br J Clin Pharmacol. 1987 Sep;24(3):281-2. doi: 10.1111/j.1365-2125.1987.tb03170.x.
8
Review of yellow cards--1986 and 1987.
Br Med J (Clin Res Ed). 1988 May 7;296(6632):1319. doi: 10.1136/bmj.296.6632.1319.
9
Demography of the UK adverse reactions register of spontaneous reports.
Health Trends. 1984 Aug;16(3):49-52.
10
Immortality for old drugs?
Lancet. 1984 Jun 30;1(8392):1460-1. doi: 10.1016/s0140-6736(84)91946-9.
引用本文的文献
1
Development of new drugs in man: a review.
J R Soc Med. 1986 Feb;79(2):96-9. doi: 10.1177/014107688607900210.
2
Adverse reactions in ten years' general practice, computer analysed.
J R Soc Med. 1986 Mar;79(3):145-8. doi: 10.1177/014107688607900306.
本文引用的文献
1
Post-marketing surveillance of licensed medicinal and other products.
Health Bull (Edinb). 1981 Nov;39(6):356-66.
2
Postmarketing surveillance of adverse drug reactions in general practice. I: search for new methods.
Br Med J (Clin Res Ed). 1981 Apr 4;282(6270):1131-2. doi: 10.1136/bmj.282.6270.1131.
3
Zomepirac and cardiovascular deaths.
Lancet. 1983 Oct 15;2(8355):908. doi: 10.1016/s0140-6736(83)90888-7.
Zotero 插件